Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Hodgkin Disease 50Lymphoma 45Testicular Neoplasms 13Teratoma 12HIV Infections 12Acquired Immunodeficiency Syndrome 11Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Non-Hodgkin 9Head and Neck Neoplasms 8Endodermal Sinus Tumor 8Testicular Germ Cell Tumor 7Sarcoma, Kaposi 7Neoplasms 7Carcinoma, Embryonal 7Seminoma 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 6Ovarian Neoplasms 5Ovarian Germ Cell Cancer 5Recurrence 4Neoplasms, Germ Cell and Embryonal 4Neoplasm Metastasis 4Carcinoma, Squamous Cell 4Vulvar Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Teratoma, Testicular 2Skin Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Drug-Related Side Effects and Adverse Reactions 2Dendritic Cell Sarcoma, Interdigitating 2

Interventions

Cisplatin 8Carboplatin 8Bevacizumab 8Pleurodesis 7Talc 6Paclitaxel 6Docetaxel 5Povidone-Iodine 4Doxycycline 4Taxes 3Gemcitabine 3Drug Therapy 3Chest Tubes 3aldesleukin 2Zoledronic Acid 2Trastuzumab 2Thoracoscopy 2Sodium Chloride 2Silver Nitrate 2Pharmaceutical Preparations 2Nivolumab 2Interleukin-2 2Fluorodeoxyglucose F18 2Fentanyl 2Erlotinib Hydrochloride 2Cetuximab 2Bortezomib 2viscum album peptide 1tocilizumab 1tipifarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pleural Effusion, Malignant × Bleomycin × Clear all
NCT00002872 2023-06-22

Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions

Eastern Cooperative Oncology Group

Phase 3 Completed
480 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡